Office of Personalized Healthcare

Compared to previous personalized bills, HR 5440 includes much more toothy language about FDA regulatory muscle over companion tests. It would also create an Office of Personalized Healthcare to recommend which tests should be regulated and how personalized medicine products should be reimbursed, and form several committees to address translational challenges of personalized medicine.

Researchers hope to tease out the signature effects that different carcinogens leave on the genome to determine their contributions to disease, Mosaic reports.

The Wall Street Journal looks into the cost of new gene therapies.

An Imperial College London-led team reports that it was able to use a gene drive to control a population of lab mosquitos.

In PNAS this week: genomic effects of silver fox domestication, limited effect of mitochondrial mutations on aging in fruit flies, and more.